PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+28.63%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$896M
AUM Growth
–
Cap. Flow
+$896M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
71.41%
Holding
87
New
80
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$226M |
| 2 |
Sarepta Therapeutics
SRPT
|
$104M |
| 3 |
Neurocrine Biosciences
NBIX
|
$68M |
| 4 |
Biogen
BIIB
|
$49.8M |
| 5 |
Talphera
TLPH
|
$46.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 88.47% |
| 2 | Financials | 0.8% |
| 3 | Real Estate | 0.11% |
| 4 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HMA
76
DELISTED
HEALTH MGMT ASSOC INC CL-A
HMA
| $20K | ﹤0.01% | +1,265 | New | +$20K |
|
|
WOOF
77
DELISTED
VCA Inc.
WOOF
| $20K | ﹤0.01% | +780 | New | +$20K |
|
|
ENDP
78
DELISTED
Endo International plc
ENDP
| $19K | ﹤0.01% | +530 | New | +$19K |
|
|
AMRN
79
Amarin Corp
AMRN
$311M
| – | – | 0 | – | – |
|
80
iShares Biotechnology ETF
IBB
$5.6B
| – | – | 0 | – | – |
|
|
FRTX
81
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| – | – | 0 | – | – |
|
|
SGEN
82
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – | 0 | – | – |
|
|
ARNA
83
DELISTED
Arena Pharmaceuticals Inc
ARNA
| – | – | 0 | – | – |
|
|
NAVB
84
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| – | – | 0 | – | – |
|
|
OPTR
85
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
| – | – | 0 | – | – |
|